377 related articles for article (PubMed ID: 6893459)
1. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
Brossard JH; Garon J; Lepage R; Gascon-Barré M; D'Amour P
Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
[TBL] [Abstract][Full Text] [Related]
3. [Osteitis fibrosa cystica von Recklinghausen].
Røkke O; Due J; Dale K
Tidsskr Nor Laegeforen; 1990 Mar; 110(8):960-1. PubMed ID: 2321226
[TBL] [Abstract][Full Text] [Related]
4. Late increase in serum 1,25-dihydroxyvitamin D one month after surgery for adenomatous hyperparathyroidism.
D'Amour P; Gilbert F; Gascon-Barre M; Boutin JM; Havrankova J; Bélanger R; Matte R
Clin Endocrinol (Oxf); 1986 Apr; 24(4):349-58. PubMed ID: 3755658
[TBL] [Abstract][Full Text] [Related]
5. Primary hyperparathyroidism with low serum 1,25-dihydroxyvitamin D levels.
Wortsman J; Haddad JG; Posillico JT; Brown EM
J Clin Endocrinol Metab; 1986 Jun; 62(6):1305-8. PubMed ID: 3754562
[TBL] [Abstract][Full Text] [Related]
6. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and hypocalcemia in man.
Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW
J Clin Endocrinol Metab; 1980 Mar; 50(3):480-4. PubMed ID: 6892641
[TBL] [Abstract][Full Text] [Related]
8. Daily follow-up of serum parathyroid hormone and calcium after surgery for primary hyperparathyroidism.
Debruyne F; Delaere P; Ostyn F; Van den Bruel A; Bouillon R
J Otolaryngol; 1999 Dec; 28(6):305-8. PubMed ID: 10604157
[TBL] [Abstract][Full Text] [Related]
9. Marked direct suppression of primary hyperparathyroidism with osteitis fibrosa cystica by intravenous administration of 1,25-dihydroxycholecalciferol.
Patron P; Gardin JP; Borensztein P; Prigent A; Paillard M
Miner Electrolyte Metab; 1989; 15(6):321-5. PubMed ID: 2615719
[TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
11. The interrelationships among prolactin, 1,25-dihydroxyvitamin D, and parathyroid hormone in humans.
Adams ND; Garthwaite TL; Gray RW; Hagen TC; Lemann J
J Clin Endocrinol Metab; 1979 Oct; 49(4):628-30. PubMed ID: 573283
[TBL] [Abstract][Full Text] [Related]
12. Circadian rhythms for calcium, inorganic phosphorus, and parathyroid hormone in primary hyperparathyroidism: functional and practical considerations.
Lobaugh B; Neelon FA; Oyama H; Buckley N; Smith S; Christy M; Leight GS
Surgery; 1989 Dec; 106(6):1009-16; discussion 1016-7. PubMed ID: 2588106
[TBL] [Abstract][Full Text] [Related]
13. [Proceedings: Normocalcemic primary hyperparathyroidism].
Drings P; Schmidt-Gayk H; Ritz E; Krempin B; Andrassy K; Röher HD
MMW Munch Med Wochenschr; 1974 May; 116(22):1107. PubMed ID: 4211600
[No Abstract] [Full Text] [Related]
14. Rickets of prematurity. Supranormal levels of serum 1,25-dihydroxyvitamin D.
Chesney RW; Hamstra AJ; DeLuca HF
Am J Dis Child; 1981 Jan; 135(1):34-7. PubMed ID: 6969986
[TBL] [Abstract][Full Text] [Related]
15. Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism.
LoCascio V; Adami S; Galvanini G; Ferrari M; Cominacini L; Tartarotti D
N Engl J Med; 1985 Oct; 313(18):1123-5. PubMed ID: 3840228
[TBL] [Abstract][Full Text] [Related]
16. Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria.
Van Den Berg CJ; Kumar R; Wilson DM; Heath H; Smith LH
J Clin Endocrinol Metab; 1980 Nov; 51(5):998-1001. PubMed ID: 6893460
[TBL] [Abstract][Full Text] [Related]
17. Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity.
Nordenström E; Westerdahl J; Isaksson A; Lindblom P; Bergenfelz A
World J Surg; 2003 Feb; 27(2):212-5. PubMed ID: 12616439
[TBL] [Abstract][Full Text] [Related]
18. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
[TBL] [Abstract][Full Text] [Related]
19. ATYPICAL PRIMARY HYPERPARATHYROIDISM DUE TO HYPOVITAMINOSIS D.
Gaţu AA; Velicescu C; Novac R; Mogoş V; Brănişteanu DD
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):384-9. PubMed ID: 26204641
[TBL] [Abstract][Full Text] [Related]
20. Postoperative course of serum parathyroid hormone and calcium after surgery for primary hyperparathyroidism.
Debruyne F; Delaere P; Vander Poorten V
Acta Otorhinolaryngol Belg; 2001; 55(2):153-7. PubMed ID: 11441474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
